SANTA CLARA, Calif., Sept. 19 /PRNewswire-FirstCall/ --
Applied Imaging Corp. (Nasdaq: AICX) announced the release of Ariol(TM), the
Company's latest cellular imaging system. Ariol is a high-throughput system
designed to automate and standardize the analysis of immunohistochemistry
(IHC) and fluorescence in-situ hybridization (FISH) test results in clinical
laboratories. The Ariol system includes a suite of applications that assist
the pathologist and oncologist in their review of key breast cancer IHC tests.
The system is also designed to detect micrometastatic cancer cells that may be
found in bone marrow and other clinical samples.
Ariol consists of a scanning microscopy system and an automated microscope
slide handler to meet the needs of the highest-volume clinical laboratory
customers. The Ariol system, the second generation of the Company's pioneering
MDS(TM) System, is being released to clinical laboratories and research sites
for research use, pending application to the Food and Drug Administration
(FDA) for specific clearances. The Company expects to offer additional
applications, including automated FISH analysis for DNA probes, in the near
future.
"I am very pleased to announce that we have achieved another important
milestone for Applied Imaging. The Ariol system adds significantly to the
range of products available within our OncoPath(TM) product line, that
includes the SPOT(TM) systems released in May this year," said Applied Imaging
CEO Carl Hull. "We are responding to a rapidly increasing market demand for
the automated analysis of protein and DNA probe tests. External estimates
indicate that gene-based testing is growing at 20-30% per year in major
clinical laboratories."
Mr. Hull continued, "I am very positive about the outlook for this
exciting new technology based on initial feedback from potential customers who
have previewed Ariol. We now have approximately 50 of our MDS and SPOT
OncoPath systems installed globally with customers using them for a wide range
of applications. We believe that Ariol and MDS are the only clinical imaging
systems capable of analyzing both gene and protein expression levels using
brightfield and fluorescence illumination."
About Applied Imaging
Applied Imaging Corp., based in Santa Clara, California, is the leading
supplier of automated imaging systems utilized in genetics and pathology
laboratories for the analysis of chromosomes in cancer and prenatal disorders.
The Company markets a range of clinical and research imaging systems for
fluorescence and brightfield microscopy applications, including the Company's
Ariol(TM), MDS(TM), SPOT(TM), CytoVision(R), PowerGene(R) and QUIPS(R) product
lines. Applied Imaging has installed in excess of 2,500 systems in over
1,000 laboratories in more than 60 countries.
This press release contains forward-looking statements as defined in the
Private Securities Litigation Reform Act of 1995, regarding, among other
matters, the Company's expectation of applying to the Food and Drug
Administration for specific clearances for the Ariol system, the Company's
expectation of offering additional applications, including automated FISH
analysis for DNA probes, in the near future, market demand for the automated
analysis of protein and DNA probe tests, and prospects for commercial success
of the Ariol system. Applied Imaging's actual results could differ materially
from those anticipated in these forward-looking statements as a result of a
number of risks, uncertainties and other factors, including, but not limited
to, the risks associated with marketing and obtaining FDA clearance for our
Ariol system and those risks discussed in Applied Imaging's filings with the
Securities and Exchange Commission, including the amended Form 10-K for the
year ended December 31, 2001 as filed with the Securities and Exchange
Commission on July 25, 2002. The forward-looking statements are made as of
September 19, 2002, and Applied Imaging is under no obligation to revise or
update the forward-looking statements.
For additional information on Applied Imaging visit the Company's Web site
at http://www.aicorp.com.
SOURCE Applied Imaging Corp.
 back to top
Related links:
http://www.aicorp.com
CONTACT:
Barry Hotchkies, CFO of Applied Imaging
Corp., +1-408-562-0250; or investors/media, James Hoyne, or
general, Pam Roberts, both of FRB/Weber Shandwick,
+1-415-986-1591, for Applied Imaging Corp.
|
